Express Healthcare
Home  »  News  »  BioGenex Life Sciences launches TRIPLEX COVID-19 RT-PCR Direct

BioGenex Life Sciences launches TRIPLEX COVID-19 RT-PCR Direct

0 137
Read Article

The RT-PCR kit detects all variants of COVID-19 including Omicron

BioGenex Life Sciences has developed a RT-PCR kit for COVID-19 diagnosis, which detects COVID-19 caused by SARS COV 2 variants including “OMICRON” plus other variants.

The TRIPLEX COVID-19 RT-PCR Direct is a real-time RT-PCR test intended for the qualitative detection of SARS-CoV-2 directly from the upper respiratory swab, nasopharyngeal or oropharyngeal swabs, collected in preservative media, (VTM/UTM), pH 7.2-7.4 to provide the molecular diagnostic basis for infected patients.

Krishan Kalra, CEO, BioGenex Life Sciences mentioned, “The kit detects Omicron without RNA extraction in half the time than standard PCR DR. The product is launched nationally at Hyderabad now.”

The cost of the kit is Rs 150 plus taxes.

The National Institute of Biologicals (NIB), Noida examined the performance of this kit and found that it performed with 100 per cent accuracy & 100 per cent sensitivity. The kit detects the Omicron variant in half the time than the standard RT-PCR tests.

Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
Are you looking for ICP-MS which can increase productivity and remove time trap from your analysis?
Know More